Robert S. Kass
Affiliations: | Columbia University, New York, NY |
Google:
"Robert Kass"Mean distance: 13.38 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorWilliam Lee Williams | grad student | 1972 | University of Michigan (Physics Tree) |
Richard W. Tsien | post-doc | 1982 | Stanford |
Children
Sign in to add traineeThai V. Pham | grad student | 2001 | Columbia |
Joseph W. Cormier | grad student | 2005 | Columbia |
John R. Bankston | grad student | 2004-2009 | Columbia |
Ian W. Glaaser | grad student | 2010 | Columbia |
Priscilla J. Chan | grad student | 2012 | Columbia |
Jeremiah D. Osteen | grad student | 2007-2012 | Columbia |
Junko Kurokawa | post-doc | ||
Wai-Meng Kwok | post-doc | University of Rochester Medical Center | |
Hugues Abriel | post-doc | 1999-2001 | Columbia University Medical School |
Thomas W. Comollo | post-doc | 2015-2019 | Columbia University - College of Physicians and Surgeons and the Mailman School of Public Health |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Morgenstern TJ, Darko-Boateng A, Afriyie E, et al. (2024) Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies. Biorxiv : the Preprint Server For Biology |
Zou X, Shanmugam SK, Kanner SA, et al. (2023) Divergent regulation of KCNQ1/E1 by targeted recruitment of protein kinase A to distinct sites on the channel complex. Elife. 12 |
Zou X, Wu X, Sampson KJ, et al. (2022) Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels. Frontiers in Physiology. 13: 902224 |
Redel-Traub G, Sampson KJ, Kass RS, et al. (2022) Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension. Biomolecules. 12 |
Chen L, Peng G, Comollo TW, et al. (2022) Two small-molecule activators share similar effector sites in the KCNQ1 channel pore but have distinct effects on voltage sensor movements. Frontiers in Physiology. 13: 903050 |
Comollo TW, Zou X, Zhang C, et al. (2022) Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers. Channels (Austin, Tex.). 16: 173-184 |
Johnson M, Gomez-Galeno J, Ryan D, et al. (2021) Human iPSC-derived Cardiomyocytes and Pyridyl-Phenyl Mexiletine Analogs. Bioorganic & Medicinal Chemistry Letters. 128162 |
Cashman JR, Ryan D, McKeithan WL, et al. (2021) Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes. Journal of Medicinal Chemistry |
McKeithan WL, Feyen DAM, Bruyneel AAN, et al. (2020) Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. Cell Stem Cell |
Shandell MA, Quejada JR, Yazawa M, et al. (2019) Detection of Na1.5 Conformational Change in Mammalian Cells Using the Noncanonical Amino Acid ANAP. Biophysical Journal |